Navigation Links
Valeant Pharmaceuticals Provides Efinconazole Update
Date:5/2/2013

LAVAL, Quebec, May 2, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that we agreed this afternoon that the launch of efinaconazole, our topical product candidate for the treatment of onychomycosis, will not occur until after the September 2013 arbitration hearing to resolve the breach of contract dispute with Anacor Pharmaceuticals (NASDAQ: ANAC). As a result, the preliminary injunction hearing which was scheduled for May 6-8, 2013 has been canceled. Valeant intends to vigorously contest Anacor's claims and continues to expect to launch the product in 2013.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Forward-looking Statements

This press release may contain forward-looking statements, including, but not limited to, statements regarding our expectation with respect to the FDA response and our launch plans with respect to efinaconazole.  Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target", or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in t
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ... POC Diagnostics Market 2015-2019" report to their offering. ... POC Diagnostics market to grow at a CAGR of ... POC diagnostics are IVD devices and tools used for ... The use of these devices helps in the rapid ...
(Date:3/3/2015)... , March 3, 2015  Michigan brothers Dominique ... condition called arrhythmogenic right ventricular dysplasia, or ARVD, a disease ... of sudden death among young athletes. In 2007, ... a basketball game. They later tested Dominique and found his ... a February 19, 2015 story in The Ann Arbor ...
(Date:3/3/2015)... , March 3, 2015  Web Industries, ... manufacturing services in the Medical Device, Advanced Composites, ... been named a 3M Medical Specialties Preferred Converter ... status will allow companies to streamline their supply ... of contact for 3M materials, intermediate converting services, ...
Breaking Medicine Technology:Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3Web Industries Receives 3M Preferred Converter Status 2
(Date:3/4/2015)... 04, 2015 The medical device landscape ... management forgot – or ignored or didn't know – ... market based on physician input before proceeding to design ... specifically, founders – become so enamored of an innovative ... Will physicians use the device?” says Dr. Kathryn ...
(Date:3/3/2015)... 2015 On February 24, 2015, a ... United States District Court for the Northern District of ... well as insurance companies Balboa, QBE, and Newport Management. ... No. 3:14-cv-152.) , The Plaintiff, a Ms. Dolores Gorsuch, ... force her to buy too much insurance at rates ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Longtime parent ... with CARE Surrogacy Center for a candid ... originally appearing online is an exhilarating revelation of his ... have led him from Australia to the birth of ... press interchange, Tolga Umar, CEO and Founder of CARE ...
(Date:3/3/2015)... March 03, 2015 Dan E. Chambers, an ... special focus on capital crimes, recently spoke on the radio ... trial. The hosts of the Independent Journal Review radio show ... working first as a prosecutor and now as a criminal ... decisions made in the trial and sentencing of this high-profile ...
(Date:3/3/2015)... 04, 2015 The report “Alopecia – ... therapeutic development for Alopecia. Alopecia is the loss of ... main types of alopecia. Causes for alopecia include aging, ... alopecia may include male pattern hair loss, female diffuse ... can be classified as focal or diffuse and by ...
Breaking Medicine News(10 mins):Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 3Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4
... ... technology shows its latest UV-LED curing systems for UV printing applications in Guangzhou. , ... (PRWEB) March 8, 2010 -- Printing ... evolution of UV-LED curing technology from Phoseon for UV printing applications . The Phoseon ...
... three early-stage breast cancer patients who received genomic testing ... fully understand their discussions with physicians about their test ... four experienced distress when receiving their test results. ... of the American Cancer Society, the findings suggest there ...
... ... ... , , ... WASHINGTON , March ...
... ... Sponsors for the 2010 Cinco de Mayo Half Marathon and the 12th Annual “Reaching for ... ... Pediatric Cancer Research Foundation (PCRF) announced the official sponsors for the annual “Reaching for ...
... ... ... ... ...
... tips to prevent early tooth decay, damage , SATURDAY, March ... children,s teeth a healthy start is to begin dental care ... for keeping kids, teeth in tip-top shape: , Visit ... six months of the eruption of a child,s first tooth, ...
Cached Medicine News:Health News:Phoseon Technology Continues Worldwide Rollout of UV-LED Curing Systems with Attendance at Printing South China 2010 2Health News:Improvements needed in genomic test result discussions 2Health News:Illinois State Senator Cullerton Recognized for Advocacy Work on Mental Health Issues 2Health News:Illinois State Senator Cullerton Recognized for Advocacy Work on Mental Health Issues 3Health News:Illinois State Senator Cullerton Recognized for Advocacy Work on Mental Health Issues 4Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 3Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 2Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 3Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 4Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 5Health News:Protect Your Baby's Smile 2
Aire-Cuf® tracheostomy tubes are ideal for short-term to medium-term ventilator support....
... in both neonatal and pediatric sizes., ,The ... it has a cuff. When completely deflated, it ... , ,TTS™ (tight-to-shaft) tubes have the profile ... a cuff, if and when needed. , ...
... TTS™ tracheostomy tubes are available in both neonatal ... like an uncuffed tube, but it has a ... the shaft of the tube. , ,TTS™ ... tube with the insurance of a cuff, if ...
... tracheostomy tubes are intended for ... length fixed neck flange tube ... ,Adjustable neck flange Hyperflex™ tracheostomy ... both horizontal and vertical shaft ...
Medicine Products: